|
Volumn 255, Issue 11, 2008, Pages 1679-1686
|
Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds
|
Author keywords
Anti thrombotic; Cerebral microbleeds; Haemorrhage; Infarct
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CLOPIDOGREL;
WARFARIN;
ADULT;
AGED;
ARTICLE;
BLEEDING;
BRAIN HEMORRHAGE;
BRAIN INFARCTION;
CEREBROVASCULAR ACCIDENT;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
RECURRENT DISEASE;
RISK ASSESSMENT;
RISK REDUCTION;
STROKE;
SURVIVAL;
BRAIN;
BRAIN ISCHEMIA;
CEREBRAL HEMORRHAGE;
FIBRINOLYTIC AGENTS;
HUMANS;
KAPLAN-MEIERS ESTIMATE;
MAGNETIC RESONANCE IMAGING;
MULTIVARIATE ANALYSIS;
MYOCARDIAL INFARCTION;
REGRESSION ANALYSIS;
RISK;
STROKE;
|
EID: 58549108211
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-008-0967-7 Document Type: Article |
Times cited : (160)
|
References (19)
|